sorafenib,bevacizumab,atezolizumab
roche,bayer
[]
delighted to present the results of our sub-analysis of the imbrave150 study at gi symposium. antibiotics exposure affect outcomes of immunotherapy but not sorafenib recipients in ahcc. is it a matter of bugs? much more to be understood! 
Medical Oncology Resident; Clinical Research Fellow; Imperial College, London; University Campus Bio-Medico interested in HCC; BTC and pancreatic cancer